Co-Diagnostics, Inc. Financing Receivable, after Allowance for Credit Loss, Current
Co-Diagnostics, Inc. (CODX) had Financing Receivable, after Allowance for Credit Loss, Current of $18.75 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2024-03-14
- 2023-09-30: Financing Receivable, after Allowance for Credit Loss, Current $18.75K.
- 2023-06-30: Financing Receivable, after Allowance for Credit Loss, Current $37.50K.
- 2023-03-31: Financing Receivable, after Allowance for Credit Loss, Current $37.50K.
- 2022-12-31: Financing Receivable, after Allowance for Credit Loss, Current $75.00K.
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-09-30 | $18.75K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $37.50K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $37.50K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $75.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $75.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $35.20K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $75.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $75.00K 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |